GeckoSystems Intl. Corp. (GOSY)

[XenaLives]

George MacLeod is a serial offender. I've found evidence of multiple cons and connection with people who've been sent to jail (David Stocker) and an institution about to be prosecuted by the SEC (Big Apple).

I've found him connected with the same gang in the Sushi Trend con associated with fraud perpetrated on GeckoSystems ( Reed Wallace, Jerry Alexander).

I've found him currently involved in a con and I've found him involved with a Canadian company that was reorganied several times for serial pump and dumps, APIT.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=71297017

During MacLeod's brief tenure with GeckoSystems he introduced fake investors, defrauded the company and potential legitimate investors, and tried to sell the company's technology for pennies on the dollar. He also brought "fly ash" Wallace on board.

Just like at Sushi Trend and GeckoSystems, MacLeod didn't last long at PHARMESSEN. It would be interesting to talk to these people. I bet it would be the same story. It looks like MacLeod and that crew lasted less than eight months at PHARMESSEN.


http://web.archive.org/web/20031206184845/http://pharmessen.com/
12/06/2003

DUSAN G. NINKOV DVM MSc PhD
President & CEO

ANGUS J. MacDONALD
Vice President & Business Development Director

KENNETH B. FRESHWATER
Technical Operations Director

DUSAN M. LEKIC MD MSc PhD
Research & Development Director

PETER V. PALLAI BSc MSc PhD
Chemistry Consultant

WOLFRAM JUNGHANNS BSc MSc PhD
Production Consultant

VESNA SEGOS BSc MSc
Pharmaceutical Consultant

Z.B. WEISS BFA BA MFA
Marketing Director

http://web.archive.org/web/20040327143458/http://www.pharmessen.com/

PHARMESSEN EXPERTS

DUSAN G. NINKOV DVM MSc PhD
President & Chairman

GEORGE MACLEOD
CEO

GERRY BERG
CFO

FRANK CHAVIANO
PhD Public Health
VP of Product Development
[e-mail]

WADE STEVERSON
Vice President Sales/Marketing
[e-mail]

EZRA BEJAR MSc PhD
Vice President Research and Development
[e-mail]

WOLFRAM JUNGHANNS BSc MSc PhD
Production Consultant

VESNA SEGOS BSc MSc
Pharmaceutical Consultant

http://web.archive.org/web/20051107224736/http://66.34.178.32/press/press.asp?id=11

Pharmessen Scientific, Inc. Announces Management Changes


SAN DIEGO--(BUSINESS WIRE)--August 30, 2004--Pharmessen Scientific, Inc. (Other OTC: PASC.PK - News), a global nutraceutical research company focused on providing leading supplements for better general health, announced today that founder Dr. Dusan G. Ninkov has resumed his CEO role on an interim basis, a post he held up until February of this year. In connection with this change, the company has relieved its Chief Executive Officer and Chief Financial Officer from their respective positions. Also on an interim basis, the CFO function will be performed with the assistance of the company’s outside accounting firm. The move was part of a larger effort, including a reduction of other administrative personnel, for the purpose of reallocating resources from overhead to sales and production support. "This change in management signals a return to fundamentals, and a re-unification of managerial philosophy with shareholder value," said Dr. Ninkov. "We believe that Pharmessen has not realized sales growth to a level consistent with the quality of its existing product, and we are actively reducing overhead to dedicate all available resources to the company’s sales effort." Consistent with this renewed priority on sales, Pharmessen also announced the appointment of Gabriel Luna de la Fuente as Chief Operating Officer. De la Fuente is a seasoned sales veteran, with successful tenures with Coca-Cola, Champions Sports Memorabilia, Univision Television, and El Informador Magazine. "Pharmessen has an exciting product line, and it has been well-received by the market," says de La Fuente. "My belief is that this company’s growth will and should come from profits, which in turn come from sales. That will be my focus."